AZTherapies’ scientific approach recognizes neuroinflammation as a root cause of serious neurodegenerative disease. By shifting the brain’s own immune cells, the microglia, from an aggressive, pro-inflammatory state to a neuroprotective state, we aim to treat a broad array of serious diseases.
Our lead program is built on a multi-modal approach that seeks to stop or slow the progression of early Alzheimer’s disease. We are also advancing candidates for the treatment of ALS and other neurodegenerative diseases.
We have assembled unique, results-driven and highly engaged leadership and advisory teams to advance our pipeline, improve the lives of patients with serious neurodegenerative diseases, and build a company of exceptional value.